From ISOGG Wiki
|Headquarters||San Diego, California, USA|
Pathway Genomics is a privately held personal genomics company based in San Diego, California. Using DNA genetic testing technologies, the company conducts services to generate personalized reports about an individual’s carrier status, drug (medication) response, propensity for the development of certain complex diseases, as well as ancestral history. The company provides these personal genetic reports to physicians and their patients. Pathway Genomics owns and operates a federally certified and California state-licensed on-site laboratory. According to its website, Pathway Genomics reports on a number of health conditions including Alzheimer’s disease, diabetes, hypertension, asthma, rheumatoid arthritis, cystic fibrosis, and beta-thalassaemia, as well as screening for drug responses for such medications as warfarin and clopidogrel.
Pathway Genomics was founded in 2008 by Jim Plante, an entrepreneur in the industries of technology and preventive healthcare. Plante founded four other venture capital-supported technology companies and he is responsible for launching new product lines and services in the consumer products, automotive, wireless, and risk-management service industries. Pathway Genomics’ scientific team is led by David Becker, Ph.D., Chief Scientific Officer. Dr. Becker is most notably recognized for his contribution to Alzheimer’s disease research.
- New DTC Genetics Firm Pathway Genomics Launches." GenomeWeb Daily News, 15 July 2009.
- Official Pathway Genomics website
- Pathway Genomics blog
- Pathway Genomics on Facebook
- Pathway Genomics on Twitter
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pathway Genomics".|